Alpha Cognition INC S-1 registration statements

Alpha Cognition Inc. has filed an amendment to its Form S-1 registration statement, detailing its commercialization strategy for ZUNVEYL and providing updates on its clinical programs and recent corporate activities.

Alpha Cognition has filed a registration statement for the resale of 1.4 million common shares by existing stockholders, following the recent FDA approval of their Alzheimer's drug, ZUNVEYL.

Alpha Cognition Inc. files a registration statement to increase its proposed maximum aggregate offering price by $6,786,409.07 through the sale of additional common shares and pre-funded warrants.

Alpha Cognition USA Inc. enters into an employment agreement with Henry Du as VP, Finance and Accounting, while the company prepares for a public offering.

Alpha Cognition Inc. is offering 2,500,000 common shares and pre-funded warrants to purchase up to 2,500,000 additional common shares, aiming for a Nasdaq Capital Market listing.

Alpha Cognition registers 22.6 million shares for resale, paving the way for potential commercial activities following FDA approval of its Alzheimer's treatment, ZUNVEYL.

Alpha Cognition aims to uplist to the Nasdaq Capital Market through a $25 million offering of common shares and pre-funded warrants, focusing on commercializing its newly FDA-approved Alzheimer's treatment.

Alpha Cognition is planning a firm commitment offering of common shares and warrants, aiming for a Nasdaq listing and further development of its Alzheimer's and TBI treatments.

Alpha Cognition Inc. files for a firm commitment offering of shares and warrants to fund Alzheimer's drug development and Nasdaq uplisting.

Alpha Cognition Inc. files an amendment to its S-1 registration statement, paving the way for a potential public offering and resale of common shares by selling stockholders.

Alpha Cognition Inc. files an amendment to its registration statement for the resale of common shares by selling stockholders, as it awaits FDA review of its Alzheimer's drug, ALPHA-1062.

Alpha Cognition has filed an amendment to its registration statement for the offering and resale of up to 42,676,511 common shares by selling stockholders.

Alpha Cognition Inc. has filed a registration statement for the potential offering and resale of up to 42,676,511 common shares by selling stockholders.